Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 17
2003 19
2004 16
2005 14
2006 19
2007 19
2008 19
2009 24
2010 24
2011 44
2012 43
2013 42
2014 35
2015 29
2016 27
2017 21
2018 27
2019 25
2020 36
2021 38
2022 39
2023 32
2024 33
2025 38
2026 37
2027 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

615 results

Results by year

Filters applied: . Clear all
Page 1
Finerenone in Persons with Chronic Kidney Disease without Diabetes.
Heerspink HJL, Neuen BL, Agarwal R, Cherney DZI, Lam CSP, Tuttle KR, Wanner C, Sarafidis P, Jongs N, Smeijer JD, Brinker M, Rethemeier N, Schloemer P, Vesterinen P, Goldsbury D, Dizayee S, Mares JW, Perkovic V; FIND-CKD Investigators. Heerspink HJL, et al. N Engl J Med. 2026 Aug 6;395(6):533-545. doi: 10.1056/NEJMoa2604625. Epub 2026 Jun 4. N Engl J Med. 2026. PMID: 42246672 Clinical Trial.
Evidence-based clinical practice guidelines for metabolic dysfunction-associated steatotic liver disease (MASLD) 2026.
Akuta N, Kogiso T, Ikejima K, Otsuka M, Kawaguchi T, Kawanaka M, Takahashi H, Tamaki N, Nakagawa H, Hikita H, Fujii H, Yamaguchi K, Yoneda M, Kon K, Uchiyama A, Seko Y, Sakane S, Shigefuku R, Fujiwara N, Iwaki M, Kobayashi T, Adachi T, Takeuchi Y, Tsutsumi T, Nakano D, Shibayama K, Urata N, Miyaaki H, Kuroda H, Koseki M, Sone H, Matsubayashi Y, Kakisaka K, Takai A, Notsumata K, Seike M, Takei Y, Takeyama Y, Eguchi S, Watanabe S, Isomoto H, Yotsuyanagi H, Itoi T, Takehara T, Mochida S. Akuta N, et al. Among authors: fujii h. J Gastroenterol. 2026 Jun;61(6):693-710. doi: 10.1007/s00535-026-02408-2. Epub 2026 May 13. J Gastroenterol. 2026. PMID: 42120590 Free PMC article. Review.
Hypocalcemia and cardiovascular mortality in cinacalcet users.
Goto S, Hamano T, Fujii H, Taniguchi M, Abe M, Nitta K, Nishi S. Goto S, et al. Among authors: fujii h. Nephrol Dial Transplant. 2024 Mar 27;39(4):637-647. doi: 10.1093/ndt/gfad213. Nephrol Dial Transplant. 2024. PMID: 37777840 Free article.
Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases: A Randomized Clinical Trial.
Neuen BL, Perkovic V, Agarwal R, Cherney DZI, Lam CSP, Wanner C, Tuttle KR, Sarafidis P, Barratt J, Burgner A, Chen X, Chew-Wong A, Dobronravov VA, Floege J, McCafferty K, Nangaku M, Packham D, Papachristou E, Pergola PE, Speeckaert MM, Subbiah A, Tang SCW, Tang S, Yeo SC, Jongs N, Smeijer JD, Berger M, Brinker M, Dayoub R, Elliott J, Li N, Mueller K, Rethemeier N, Finkelsztein MY, Heerspink HJL; FIND-CKD Investigators. Neuen BL, et al. JAMA. 2026 Jul 21;336(3):224-235. doi: 10.1001/jama.2026.9923. JAMA. 2026. PMID: 42246414 Free article. Clinical Trial.
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis.
Li J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH, Fujii H, Wu Y, Kam LY, Ji F, Li X, Chien N, Wei M, Ogawa E, Zhao C, Wu X, Stave CD, Henry L, Barnett S, Takahashi H, Furusyo N, Eguchi Y, Hsu YC, Lee TY, Ren W, Qin C, Jun DW, Toyoda H, Wong VW, Cheung R, Zhu Q, Nguyen MH. Li J, et al. Among authors: fujii h. Lancet Gastroenterol Hepatol. 2019 May;4(5):389-398. doi: 10.1016/S2468-1253(19)30039-1. Epub 2019 Mar 20. Lancet Gastroenterol Hepatol. 2019. PMID: 30902670
Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD.
Takahashi H, Kessoku T, Kawanaka M, Nonaka M, Hyogo H, Fujii H, Nakajima T, Imajo K, Tanaka K, Kubotsu Y, Isoda H, Oeda S, Kurai O, Yoneda M, Ono M, Kitajima Y, Tajiri R, Takamori A, Kawaguchi A, Aishima S, Kage M, Nakajima A, Eguchi Y, Anzai K. Takahashi H, et al. Among authors: fujii h. Hepatol Commun. 2022 Jan;6(1):120-132. doi: 10.1002/hep4.1696. Epub 2021 Jun 17. Hepatol Commun. 2022. PMID: 34558835 Free PMC article. Clinical Trial.
Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study.
Fujii H, Iwaki M, Hayashi H, Toyoda H, Oeda S, Hyogo H, Kawanaka M, Morishita A, Munekage K, Kawata K, Yamamura S, Sawada K, Maeshiro T, Tobita H, Yoshida Y, Naito M, Araki A, Arakaki S, Kawaguchi T, Noritake H, Ono M, Masaki T, Yasuda S, Tomita E, Yoneda M, Kawada N, Tokushige A, Kamada Y, Takahashi H, Ueda S, Aishima S, Sumida Y, Nakajima A, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). Fujii H, et al. Clin Gastroenterol Hepatol. 2023 Feb;21(2):370-379. doi: 10.1016/j.cgh.2022.01.002. Epub 2022 Jan 17. Clin Gastroenterol Hepatol. 2023. PMID: 35051649
615 results